SavedAdd your journal

Journals / Arşiv Kaynak Tarama Dergisi / 2018 / Cilt: 27 - Sayı: 4

Importance of Monitoring New Drugs in Terms of Security (Pharmacovigilance)

Yeni Çıkan İlaçların Güvenlik (Farmakovijilans) Açısından İzlenmesinin Önemi

yusuf KARATAŞ
Aykut PELİT
Pages
500–506
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

KARATAŞ, Y., PELİT, A. (2022). Importance of Monitoring New Drugs in Terms of Security (Pharmacovigilance). Arşiv Kaynak Tarama Dergisi, Cilt: 27 - Sayı: 4, 500–506. https://ajindex.com/articles/449203

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. World Health Organization. Pharmacovigilance. Available from http://www.who.int/medicines/ areas/quality_safety/safety_efficacy/pharmvigi/en/. Accessed 08.02.2018. Türkiye İlaç ve Tıbbi Cihaz Kurumu. Framakovijilans. Available from http://www.titck.gov.tr/Ilac/Farmakovijilans. Accessed 08.02.2018. Institute of Medicine. The Future of Drug Safety: Promoting and Protecting the Health of the Public. Washington, DC, National Academies Press, 2006.
  2. Downing NS, Aminawung JA, Shah ND, Krumholz HM, Ross JS. Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012. JAMA. 2014;311:368-77. U.S. Food and Drug Administration. A Guide to Drug Safety terms at FDA. FDA Consumer Health Information. November 2012:1-3.